Dyne Therapeutics (NASDAQ:DYN) Issues Quarterly Earnings Results, Misses Estimates By $0.25 EPS

Dyne Therapeutics (NASDAQ:DYN – Get Free Report) posted its earnings results on Tuesday. The company reported ($0.96) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.71) by ($0.25), Zacks reports. Dyne Therapeutics Stock Performance Shares of Dyne Therapeutics stock opened at $34.13 on Thursday. The business has a 50-day simple moving […]

Leave a Reply

Your email address will not be published.

Previous post Snider Financial Group Has $1.91 Million Holdings in Otis Worldwide Co. (NYSE:OTIS)
Next post 10,183 Shares in DexCom, Inc. (NASDAQ:DXCM) Purchased by Brooktree Capital Management